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cardiovascular and metabolic health of
patients prescribed antipsychotic drugs: a
systematic review
Ruba Azfr Ali1,2, Zahraa Jalal1 and Vibhu Paudyal1*Abstract
Background: The use of atypical antipsychotics which currently form the primary choice pharmacotherapy for
several mental health conditions have been linked to cardiovascular and metabolic side effects. This systematic
review aimed to investigate the barriers to monitoring and management of cardiovascular co-morbidities in
patients prescribed antipsychotic medicines.
Methods: A protocol-led (CRD-42018106002) systematic literature review was conducted by searching Medline,
Embase, and PsycINFO databases 2003 until October 2019. Cochrane, Centre for Review and Dissemination (CRD)
and PRISMA guidelines were followed. Studies investigating barriers to monitoring and management of
cardiovascular co-morbidities in patients prescribed antipsychotic medicines were included.
Results: A total of 23 records were included. Key barriers included a) health-care system-related factors such as lack
of knowledge and expertise amongst care providers, available resources, confusion around remit and roles,
fragmentation of care such as across general practitioners and psychiatrists, and time constraints and b) patient-
related factors such as disability resulting from mental health conditions, knowledge and skills of the patients.
Conclusion: Barriers to monitoring and management of cardiovascular and metabolic health of patients taking
antipsychotic medicines are multidimensional. Apart from educational interventions directed to both patients and
health-care professionals, the results suggest a need for the improvement of wider system-related factors to
improve physical health of patients prescribed antipsychotic medicines.
Clearer guidelines, clarity of remit and roles amongst service providers are necessary in addition to educational
interventions directed at patients and health-care professionals in improving physical health monitoring,
counselling and management of patients prescribed antipsychotic medicines.
Trial registration: A protocol was developed and registered with PROSPERO as per PRISMA-P guidelines (CRD 4201
8106002).
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Patients with severe mental illnesses face inequality in
health and access to healthcare and face early deaths.
For example, a recent meta-analysis suggested that
schizophrenia is associated with a weighted average of
14·5 years of potential life lost, with females being par-
ticularly disadvantaged over males [1]. Cardiovascular
disorders including coronary heart disease and cerebro-
vascular disorders disease are the leading cause of deaths
in persons with severe mental illnesses [1, 2].
Atypical antipsychotics which currently form the pri-
mary choice pharmacotherapy for the management of
psychotic episodes in schizophrenia, bipolar disorders
and other several mental illnesses, have been linked to
cardiovascular and metabolic side effects [1]. Patients
with severe mental illnesses such as schizophrenia are at
dual disadvantage of being inherently predisposed to
metabolic abnormalities and often this is worsened by
the subsequent use of antipsychotics [1]. Results from a
meta-analysis assessing the prevalence of metabolic ab-
normalities between antipsychotic naïve patients and
chronically treated found that the rate of individual
metabolic abnormalities was significantly higher in the
chronically treated group [3].
In 2003, the Food and Drug Administration (FDA)
launched a black box warning regarding the diabetogenic
effect of antipsychotics [4]. In response to these warnings, a
panel of regulatory bodies and professional associations in-
cluding the American Diabetes Association (ADA)/Ameri-
can Psychiatric Association (APA) published a consensus
statement that recommends early and regular monitoring
of metabolic side effects among antipsychotics users [5].
Recently the National Institute for Health and Care Excel-
lence (NICE) guidelines for managing schizophrenia have in-
troduced updates to include management of cardiovascular
and metabolic abnormalities in patients with schizophrenia
[6]. The updates included: measuring bodyweight (plotted
on a chart); waist circumference, pulse and blood pressure,
fasting blood glucose, glycosylated haemoglobin (HbA1c),
blood lipid profile and prolactin levels. Additional measures
including electrocardiogram (ECG) should be conducted for
patients with specific cardiovascular risk such as diagnosis of
high blood pressure, medical history of cardiovascular dis-
ease and during hospital admission.
Despite current guidelines, rate of screening and man-
agement of metabolic and cardiovascular health has been
reported to be sparse. A study exploring the prevalence
of undiagnosed metabolic abnormalities in patients
with severe mental illnesses in England, reported a
very low proportion of patients had undergone annual
screening and monitoring for cardiovascular risks fac-
tors such as blood pressure (2%), weight (0%), waist
circumference (0%), any glucose (7%) and lipid profile
(4%) [7].Despite the positive outcomes which have been associ-
ated with the introduction of atypical antipsychotics on
the quality of life of people with severe mental illness, [8]
the associated cardiovascular and metabolic risks of these
drugs may limit their use. Given that cardiovascular disor-
ders are leading cause of deaths in patients with severe
mental disorders and quantitative data suggesting subopti-
mal follow up and monitoring practices, it is important to
understand the factors associated with sub-optimal moni-
toring, counselling and management of cardiovascular and
metabolic side effects that may be contributing to excess
morbidity and mortality in this population.
This study aimed to systematically review the barriers
to the monitoring, counselling and management of car-
diovascular and metabolic side effects in patients taking
antipsychotic medicines.Methods
Search strategy and eligibility criteria
A protocol was developed and registered (CRD
42018106002). Electronic search was performed for lit-
erature from 2003 until October 2019 using Medline,
Embase, and PsycINFO databases. Search was limited to
English language due to constraints in time and funding
to undertake the translation. This time frame was se-
lected as it corresponds to the FDA warnings for risks of
metabolic dysregulations associated with antipsychotic
medicines. A search strategy was developed based on
keywords and medical subject headings (Electronic sup-
plementary material 1). Cochrane, Centre for Review
and Dissemination (CRD) and PRISMA guidelines (Elec-
tronic supplementary material 2) were followed in con-
ducting and reporting the review.
The inclusion criteria were formulated using the PIC/o
mnemonic for qualitative evidence which stands for par-
ticipants, phenomenon of interest and the context [9].
Key inclusion criteria were: (i) patients aged ≥18 years
old using one or more antipsychotics for severe mental
illnesses; (ii) health care professionals who are involved
in the care of the patients which reported barriers to
screening, monitoring and management of cardiovascu-
lar and metabolic side effects in patients prescribed anti-
psychotic medicines. Studies which did not specify
patient antipsychotic use as inclusion criteria, but re-
ported participant perspectives around barriers to moni-
toring of cardiovascular or metabolic health in the
context of the drug use were also included in the review.Study identification and data extraction
Title and abstracts were screened for eligibility. After
duplicates removal, records with irrelevant titles or ab-
stracts were excluded from the search. Two reviewers
undertook the screening and reviewing process
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solved by consensus or after a discussion with a third
reviewer.
The extracted data included: participants characteris-
tics, data collection method, phenomenon under the
study and the study’ main findings. Each finding was
assigned a level of credibility: Unequivocal [U], Credible
[C], or Unsupported [US], according to the criteria from
the Joanna Briggs Institute [10]. Findings were rated as
unequivocal if they were directly supported by illustra-
tions. Findings were labelled as credible if they were in-
directly cited in the original study (derived from the
meaning). If the findings were drawn from the authors’
conclusion, the reviewer would label them as unsup-
ported. Inductive thematic synthesis approach was ap-
plied. Quality assessment was done using Joanna Briggs
Institute Assessment and Review Instrument (JBI-QARI)
for qualitative studies.Results
Included studies
A total of 22 records were included in the final synthesis
which related to 21 studies [11–31]. (Fig. 1).Fig. 1 PRISMA flowchart of the selection processStudy characteristics
The majority of the studies were conducted in Europe
[11, 13–15, 17, 19, 21, 23, 26, 29] and America [12, 16,
22, 24, 25, 27, 30]. Five studies recruited participants
from community mental health settings, [18, 21, 26, 29,
30] whereas 10 studies recruited participants from sec-
ondary care settings [12, 14–17, 19, 22, 24, 27, 31] and
two recruited participants from tertiary centres [11, 23]
Four studies did not specify the setting type [13, 20, 21,
25, 28]. A total of 10 studies investigated patients’ views
[12, 13, 15–18, 24, 27, 29, 30] and 10 studies focused on
providers’ prospective [11, 19–23, 25, 28, 31]. Only two
studies, [14, 26] examined the perspective of both men-
tal healthcare professionals and patients.
Among the studies that included patients, only three stud-
ies exclusively targeted regular antipsychotic drug users [17,
24, 29]. The majority of the patient focused studies recruited
participants based on clinical diagnoses with mental health
conditions but included patient perspectives in relation to
cardiovascular and metabolic health monitoring and hence
were included [13–16, 18, 25–27, 30]. Five of these studies
focused on participants diagnosed with psychosis [14, 15, 17,
24, 29] while four studies included wide range of mental
health conditions [12, 16, 18, 26].
Ali et al. BMC Psychiatry          (2020) 20:581 Page 4 of 15Various range of healthcare professionals were in-
cluded in the studies that looked at healthcare profes-
sionals’ perspectives, [11, 14, 19–23, 25, 26, 28, 31]
including mental health nurses, [11, 20, 23] community
mental health staffs [20, 21, 31] and primary care pro-
viders [22].
Full study characteristics are reported in Tables 1 and 2.
Quality of the included studies
The assessment was based on the four critical appraisal
categories of qualitative evidence): credibility, transfer-
ability, dependability, and confirmability. Of the 10 ele-
ments that are presented by the assessment tool (JBI),
most studies fulfilled at least 6 criteria. Most studies met
quality indicators related to the congruity of the selected
method to answer the research question, rigour sam-
pling and data collection method, and representation of
participants’ voice. Confirmability across the studies was
generally weak as none of the included studies failed to
provide information regarding the potential influence of
the researcher on the study results (Electronic supple-
mentary material 3).
The emerged themes
A total of 40 themes were extracted, then inductively
categorised into nine categories and further into two
synthesised findings extrinsic and intrinsic factors. A de-
tailed description of the identified themes and corre-
sponding sub-themes is reported in Table 3. Key
categories and themes are described below.
Extrinsic factors
This theme includes factors related to the patients’ com-
munity and their surrounding [12–17, 19–26, 28, 31].
Provider and health-care system factors
Care coordination and teamwork between different sec-
tors and health-care professionals were deemed essential
for timely screening and monitoring [11, 21, 22, 31]. Ac-
cording to one study, [31] low rate of physical health
examination in patients with psychosis was attributed to
the lack of care delivery integration between general
practitioners and psychiatrists. Similarly, primary care
providers complained about the lack of collaboration be-
tween health care professionals from different sectors
which resulted in difficulties to refer patients to specia-
lised care [22].
Managing general health conditions in patients with men-
tal health conditions such as diabetes were not considered as
a priority in some primary care settings [21, 25, 26]. Effective
communication between health-care providers was cited as
vital [12, 26, 28]. For instance, general practitioners pointed
out that communication difficulties often occurred during
the transfer of care across sectors (e.g. primary to secondarycare), and as a result, essential information including test re-
sults was often missed [28].
Time constraints was a main restriction for effective
interaction between health professionals and their pa-
tients [14, 20, 22, 23, 25, 26, 28]. Patients complained
about their inability to discuss their conditions with their
health-care professionals due to short consultation time
[22]. Similarly, mental health nurses were concerned re-
garding their inability to check patients’ physical health
due to their heavy work schedule [20].
The positive relationship between patients and their
health care providers were reported to be helpful for
better health outcomes [11, 15]. The patient-provider re-
lationship was reported to be indirectly influenced by
the behaviour of health care providers at the time of
consultation. Patients reported that the disinterest they
observed from the health-care professionals resulted in a
lack of trust between the two parties. Consequently, pa-
tients may hesitate to share their physical issues with
their providers [12, 26].
Lack of resources
Health professionals considered resource limitations and
restrictions imposed by funding bodies such as national
health systems and insurance companies as barriers that
hinder their ability to manage the physical health of pa-
tients [11, 20, 22, 25–27, 31].
The lack of financial support from organisational bodies
appeared to affect the quality of care delivered to manage
physical health issues in patients with mental health con-
ditions [11, 13, 20, 22, 25, 26, 28]. This factor contributed
to several issues mainly lack facilities and equipment to
screen physical health issues; lack of professional training
necessary to manage general health conditions (e.g. dia-
betes) [20, 26, 27]. Participants, particularly health care
providers in mental health clinics, reported difficulties to
collect patients’ blood sample due to the unavailability of
laboratory services at the clinic. Consequently, patients
had to be referred to another centre to carry out the ana-
lysis [27]. Similarly, mental health nurses pointed out that
lack of economic support was a major factor that hindered
embedding physical health screening and monitoring into
their clinic [11, 20, 26].
Notably, insufficient financial support appeared to im-
pair the performance of staff working in mental health
services [18, 28, 29]. The increased concerns regarding the
notable increase in resignation rate among health care
providers, as they were not satisfied with the increased
workload and decreased payment [25–27]. Patients shared
similar views regarding the costs of the available services
to manage their physical health [11, 17, 24, 27, 28]. Pa-
tients participated in lifestyle/weight loss interventions
programs complained about their inability to afford the
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patients as a barrier for their compliance with cardiovas-
cular screening [24].
Further concerns raised regarding the availably of compe-
tent staff to manage physical health issues in patients with
mental health conditions [26]. Both health-care profes-
sionals and patients agreed on the importance of profes-
sional training as it was seen as a facilitator that enables the
providers to manage comorbid general health conditions
[14, 19, 20, 25, 26, 28]. As a result, health-care professionals
in mental health-care services had to limit their efforts and
focus on managing mental health conditions only despite
co-existing morbidities such as diabetes [25, 27]. Unavail-
ability of the appointments within general practices was
also cited as a barrier [25, 26].The intervention site and the intervention characteristics
The subcategories related to this theme reflected factors re-
lated to the intervention setting and the characteristics of
the applied intervention (e.g. physical health management
programmes). Lack of access to specialist health-care pro-
fessionals or services to check physical health issues among
patients was indirectly cited as a barrier by both patients
and health-care professionals [12, 16, 21, 22, 25, 26].Both health-care professionals and patients agreed that
scarce facilities for monitoring physical health (e.g. general
practices), could result in travelling difficulties among pa-
tients and hence irregular cardiovascular follow-up [12, 26].
The intensity of the exercise sessions was highlighted as a
barrier that prevents patients from regularly participating in
exercise-based interventions [15].
Patients’ family and community factors
This theme comprises factors that are related to
patients-family/community relationship. Social support
was vital for successful management of co- morbidities
in patients with psychosis [11, 13, 15, 21, 24]. Many pa-
tients agreed that group-based interventions had a posi-
tive impact on their relationship as it contributed to new
friendships [11, 16, 21]. Furthermore, involving family
members in lifestyle modifying interventions deemed to
have positive and long-term impacts for patients and
their families [15, 21].
However, the same experience was not always associ-
ated with positive results for others [15, 29]. Anxiety
resulting from being surrounded by “strangers” repre-
sented additional burden for some patients and hence
hindered their participation in group-based interventions
[29]. A similar effect was reported by another study, [15]
Table 3 Themes, Categories and synthesised findings in relation to barriers to monitoring and management of cardiovascular and
metabolic health of patients prescribed antipsychotic medicines
Themes Category Synthesised
findings
Social context and support [14–16, 27, 29] Extrinsic factors
Lack of support from family/friends [12, 13, 21, 24]
Poor communication/ coordination between different health care providers /sectors [11,
12, 21, 22, 26, 28, 31]
Provider and healthcare system factors
Insufficient physician time [14, 20, 22, 23, 25, 26, 29]
Fragmentation of care [12, 20, 25, 27]
Patient- health-care professional relationship and communication [12, 21]
Issue of lack of clarity for responsibility for conducting physical health care [20, 21]
Lack of resources to manage healthy life style [11, 12, 17, 24, 27, 28] Lack of resources
Lack of equipment or suitable space [26–28]
Staff turnover [26, 27]
Lack of qualified staff to manage physical health issues [25]
Primary care providers are not paid enough [25]
Lack of insurance [21]
Cost of running interventions or groups [26]
Lack of access to qualified psychiatric follow-up [16, 22, 25] The Intervention site and the
intervention characteristics
Intensity of the applied intervention [15, 19]
Leadership is not making managing physical health issues among patients with SMI a
priority [21, 25, 26]
Difficulty traveling to specialised service [26]
Transportation problems [12]
Poor patient attendance [26]
Social context and support [14–16, 27, 29] Family and community factor
Lack of support from family/friends [12, 13, 21, 24]
Mental health condition related disabilities [11, 13, 17, 19, 25, 29–31] Mental health condition as a barrier Intrinsic Factors
Severity of psychotic symptoms [17, 21, 22, 24, 25, 30, 31]
Consequences associated with the side effects of the antipsychotic medications [19, 21,
25, 29]
Stigma/Isolation/estrangement [12, 14, 20, 27, 28]
Motivation level among participants regarding general health issues [16–18, 21, 23–27] Psychological factors
Participants views and behaviour toward specific intervention [15, 23, 26, 27, 29]
Participants’ views and behaviour regarding screening, monitoring of general health
issues [11, 26, 31]
Stress [12, 18, 26]
Participants’ knowledge about healthy lifestyle [21, 22, 26, 30] knowledge and skills
Participants’ knowledge about the medicines side effects [23, 27]
Lack of knowledge and training among health-care providers to manage physical health
issues [14, 19, 20, 25, 26, 28]
Functional limitation [12, 24] multiple-physical comorbidities
Negative effects of certain conditions e.g. pain [17]
Non-concordance with drug therapy [26] Compliance issues
Social context and support [14–16, 27, 29] Family and community factor
Lack of support from family/friends [12, 13, 21, 24]
Ali et al. BMC Psychiatry          (2020) 20:581 Page 10 of 15
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based exercise tended to compare their achievement
with their peers which consequently resulted in their
withdrawal from the sessions.
Intrinsic factors (patients related factors)
Mental health condition, psychological factors, partici-
pants’ knowledge and skills and existing co-morbidities
were the key barriers to undergoing screening, monitor-
ing and managing cardiovascular and metabolic issues in
patients with mental health problems (Table 3).
Mental health condition as a factor
This theme and its related sub-themes: disabilities asso-
ciated with the psychotic disorder, consequences of the
antipsychotic medications regarding participation in
physical health activities, the severity of psychiatric ill-
ness and stigma/isolation/estrangement were recognised
by both patients and care providers that negatively affect
screening, monitoring and management of cardiovascu-
lar co-morbidities [11–14, 17, 19, 21, 24, 25, 29, 31].
Severity of psychotic symptoms; adverse effects of psy-
chotropic medicines were recognised by both patients and
care providers that negatively affect screening, monitoring
and management of cardiovascular co-morbidities [11, 13,
17, 19, 25, 29–31]. A major difficulty, from health-care
professionals’ perspective, was the aggressive behaviour
and depression resulting from the psychotic symptoms
[22, 25]. Mental health nurses spoke of the need to pre-
scribe tranquilisers that would manage aggressive behav-
iour among patients with mental health conditions which
would enable better screening and monitoring [19]. Add-
itionally, patients reported that some psychotic symptoms,
mainly depression prevented them from actively partici-
pating in physical activities [13, 25].
The severity of psychotic symptoms represented an-
other barrier for screening and management of cardio-
vascular co-morbidities for both patients and health care
providers [17, 21, 22, 24, 25, 30, 31]. According to one
study, [22], around 35% of participants (community
health-care professionals) agreed that the more severe
mental health conditions, the more difficult to conduct
screening of co-morbidities. Similarly, there was a not-
able lack of cooperation among patients toward simple
procedures, including giving blood samples [19].
Both health-care professionals and patients expressed
their concerns regarding some side effects of psychotic
medicines which interfere with patients’ engagement in
physical activities [19, 21, 29, 30]. Health professionals
stated that the sedative side effects of some psychotropic
medications could make it difficult for patients to par-
ticipate in exercise-based programmes [19, 29]. Findings
of a study exploring diabetic care experience and know-
ledge among mental health-care staffs showed that lowrate of patients’ attendance to diabetes appointments
was associated with the hangover symptoms of psychotic
medicines mainly drowsiness [21].
“Mental health stigma” or having mental health condi-
tions was highlighted in several studies as a patient-
related barrier to effective screening and management of
cardiovascular co-morbidities [12, 14, 17, 24, 25]. The ef-
fect of stigma was reflected as difficulties raised from the
distorted image of being mentally ill, which can affect a
patient’s interaction with others (e.g. family). For ex-
ample, patients believed that having mental health con-
ditions compromised their relationship with their
families by assuming that they are incapable of dealing
with their daily life challenges. Consequently, patients
felt isolated and estranged among their own families and
hence hesitated to ask for help when needed [12].Psychological factors
Intrinsic psychological factors such as participants’ views,
feelings, behaviour and attitude were the most commonly
cited factors. Patients with mental health conditions
seemed to hold various views and attitudes toward their
conditions which could affect their motivation to receive
treatment of any kind. Patients highlighted negative atti-
tudes and views such as hopelessness, low self-esteem/
motivation as major barriers for receiving cardiovascular
or metabolic care [11, 12, 15, 16, 18, 21, 23, 27, 29, 31].
Motivation was perceived as a driving force for adopt-
ing healthy lifestyle among patients with mental health
conditions [16, 18, 21, 23, 27]. Patients’ optimism of a
good healthy life was strongly associated with the inten-
tions to participate in physical activity programs [24].
On the contrary, lack of motivation among patients with
mental health conditions was a major obstacle that pre-
vented adopting healthy life behaviour [21, 23, 24]. Par-
ticularly, low expectation associated with mental health
conditions acted as a barrier for some patients to initiate
physical activities.
Participants including health care providers and pa-
tients, agreed that patients’ negative views towards specific
interventions that are intended to manage cardiovascular
side effects (e.g. exercise-based interventions) could affect
their adherence or participation in the program, mainly
due to general dislike or disinterest [23, 26, 31]. Previous
unsuccessful experiences shaped participants’ views to-
wards particular intervention such as exercise [15, 29]. For
instance, patients, who underwent a failed experience, felt
distressed when their expectations were not met, and
hence, they would withdraw from the program [15].
Generally, patients expressed unfavourable attitude to-
ward physical health screening and monitoring. In sev-
eral studies, patients tended to ignore their physical
health due to several reasons including lack of concerns
Ali et al. BMC Psychiatry          (2020) 20:581 Page 12 of 15over their general health [18, 26, 31] additional to lack
sense of worth [31].
Some studied showed that patients’ excessive concerns
regarding their general health represented an additional
burden that would hinder their abilities to manage their
physical health issues [12, 18, 26].
Knowledge and skills
Health-care providers tend to agree on the importance of
having solid knowledge about cardiovascular and meta-
bolic risks associated with antipsychotic drugs and the ne-
cessary skills to manage them [19, 21, 28]. Health-care
professionals expressed their concerns about the difficulty
to identify patients in need for cardio-metabolic monitor-
ing and hence their inabilities to manage those patients
[21, 25, 26, 30] properly. For example, one study aimed to
explore mental health-care staff’s knowledge and experi-
ences to manage diabetes in patients with psychosis iden-
tified that key factors affecting diabetic care delivered by
mental health-care staff was having knowledge about dia-
betes as it increased their confidence to deal with suscep-
tible diabetic cases among patients.
Besides, participants’ knowledge about positive lifestyle
habits such as a healthy diet was cited as a facilitator for
patient’s participation in weight management programs
[21, 22, 26, 30]. Patients’ felt that having solid knowledge
about the nutritional facts was important as it helped
them adopt healthy lifestyle [13, 18]. Patients’ knowledge
about the metabolic side effects of antipsychotic medi-
cines increased their awareness of their general health
and hence motivated those to take actions (participate in
physical health activity programs) [13]. However, know-
ledge did not necessarily associate with positive health
outcomes [13, 23]. Robson et al. [23] found that around
21.7% of the respondents (n = 125/577) agreed that pa-
tients’ knowledge about the side effects of their psych-
otic medicines was associated with low adherence.
Physical co-morbidities in patients with mental health
conditions
For some patients, managing multiple-comorbidities was
stressful and difficult [11, 17, 24]. For instance, a com-
plex treatment regimen for both mental health and
chronic conditions (e.g. diabetes) caused difficulties
among patients due to the concurrent demands of com-
peting co-morbidities [11]. Also, physical complications
such as chronic pain and fatigue resulted in difficulties
for patients during exercise-based interventions [11].
Discussion
To the best of our knowledge, this is the first systematic
review of contributory factors for effective monitoring
and management of cardiovascular and metabolic co-
morbidities in patients taking antipsychotic medicines.This review identified a number of potential key factors
which affect the screening and management of physical
health issues, namely cardiovascular and metabolic side
effects of antipsychotic drugs.
Themes concerning mental health conditions as identi-
fied in this study can be related to the stigma model pro-
posed by Knaak et al. [32] and Ahmedani et al. [33].
Personal stigma refers to the self-perception of stigma.
Interpersonal stigma refers to the stigmatised attitudes/
beliefs towards individuals with mental health conditions.
Structural stigma refers to the discrimination in health-
care services that patients may encounter. Patients may
lack confidence and hesitate to share issues related to their
physical health. Evidence on studies associated with men-
tal health- stigma in health-care [32] showed that even
well-trained professionals working in mental health disci-
plines are subjected to interpersonal mental health stigma.
This can result in a lack of mutual trust between patients
and health-care professionals and hence affect information
sharing between the involved parties. Anti-stigma inter-
vention for HCPs, such as the ‘targeting the roots of
health-care provider stigma’, [34] can be useful. This
model requires improving: the ability of health-care pro-
fessionals to manage and cope with their emotions when
working with patients in challenging situations; improving
competence and confidence of staff; and addressing the
lack of awareness of one’s prejudices.
This systematic review shows that symptoms associ-
ated with severe mental health conditions often make
health-care professionals and patients engage in physical
health monitoring. Particularly, the aggression and de-
pressive symptoms associated with these conditions
alongside the sedative effects of some antipsychotic
medicines presents as a barrier to effective monitoring
and management. Appropriate choice of drug therapy is
imperative in managing symptoms of severe mental
health that can enable better communication between
patient and health-care professionals [35]. Family and
carer involvement is imperative in the process. Peer-led
support groups have also been shown to be effective in
improving hope, recovery and empowerment [36]. There
is a scope for such interventions to be tested in improv-
ing physical health monitoring programmes.
The organisational and system-related barriers to the
monitoring of physical health amongst patients taking
antipsychotic medicines require urgent attention. Frag-
mentation of care was identified to be a key barrier.
Fragmented responsibilities of specialist mental health
services, primary care including community psychiatric
clinics were shown to have led to confusion amongst
health-care professionals with regards to the roles and
responsibilities in monitoring physical health and the re-
ferral process. While NICE guideline in England pro-
vides clear remit for primary care in monitoring physical
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there is a need to improve on the knowledge of mental
health service providers on physical health and monitor-
ing. Furthermore, the studies demonstrated lack of re-
sources and funding that constrained their
responsibilities. In the UK, the one appointment one
problem culture often contributed to the problem. The
resource was also a patient-related barrier as studies de-
scribed a lack of means for the patients to afford healthy
eating and exercise.
This review suggests that having solid and trusting re-
lationship was vital for patients with mental health con-
ditions as it promotes better health outcomes. The
review highlighted a pattern of hesitation to seek help
among patients. Patients with mental health conditions
often feel isolated from the community. Subsequently,
they tend to be more independent and become their
own counsellors [37], which cause more isolation.
Therefore, considering the psych-social aspects of men-
tal health conditions by involving the family and friends
in the management process is vital.
Strengths and limitations
The current review has several limitations. Some of the
included studies in this review did not recruit patient
participants based on their use of antipsychotic drugs.
However during full text screening, it was decided to in-
clude the studies where participant accounts of barriers
to follow up and monitoring of cardiovascular side ef-
fects of antipsychotic drugs were presented in the study
results. Moreover, the included studies originated mainly
from the Western countries, which limit the generalis-
ability of our findings.
Despite the limitations, this review provides an insight
into potential factors influencing screening and manage-
ment of cardiovascular and metabolic side effects of anti-
psychotics. The review employed an inductive thematic
synthesis of qualitative studies of participants’ perceptions
from various backgrounds. Using such an approach pro-
vides reflexivity as it involves exploring the available evi-
dence from participants’ perspectives. Besides, our
flexibility in the study inclusion criteria needs to be con-
sidered when generalising the study findings. Further-
more, the methodological quality of included studies was
assessed using Joanna Briggs (BJI) assessment tools, which
provides uniform and structured evaluation of the studies.
Implications for practice
Despite the evidence and guidelines that support the im-
portance management of cardiovascular and metabolic
side effects of antipsychotics, regular assessment of the
implementation of such guideline is imperative. Partici-
pants of the studies included in the systematic review
prefer integrated models of monitoring and managementof both physical and mental health, and there is a need
to minimise fragmentation of care. This can be facili-
tated by addressing the contributory factors to monitor-
ing and management of the side effects as identified in
this systematic review.
Individualised interventions to tailor the needs of the
patients shown to minimise barriers to participation in
exercise-based interventions. Patients with severe mental
health conditions often face barriers to managing their
physical health due to negative symptoms and cognitive
impairment. Therefore, knowledge-based interventions
alone are not adequate. Persistent and sustainable in-
volvement is necessary. Peer-led support network is
known to be important in promoting engagement in
physical exercise. These are particularly important where
patients lack family and friends support. Funding bodies
and stakeholders must understand the needs of their
employers. This can be fulfilled by promoting profes-
sional development within the organisation.
Previously, suggestions have been made around clin-
ical, particularly nursing staff being trained to manage
both physical and mental health issues in order to pro-
vide person-centred care. Previous literature has shown
that nurses are generally in favour of physical health care
as part of their role [38]. However, those without the
background of generalist nurse training were less com-
fortable about their expertise. Appropriate reimburse-
ments should be provided to uptake additional roles in
community mental health and specialist psychiatric
units.
Future directions
Currently, this review suggests that numerous patients
prescribed antipsychotics are not properly monitored,
counselled or managed for cardiovascular and metabolic
side effects. The limited number of the available studies
addressed factors barriers/facilitators for screening and
management of antipsychotics associated cardiovascular
and metabolic issues. This suggests poor empirical evi-
dence which underpins current information practice in
contributory factors for the management of cardiovascu-
lar and metabolic side effects of antipsychotic medicines.
Further research is required to address contributory fac-
tors for sub-optimal management of cardiovascular and
metabolic side effects of antipsychotics from the per-
spectives of patients, health-care professionals, family
and carers of patients with severe mental health
problems.
While this review focused on barriers for screening
and management of cardiovascular co-morbidities in pa-
tients with mental health conditions, future research
should be directed to elicit facilitators to neutralise those
barriers. Furthermore, future research should target
stigma facilitators at different levels. Further studies on
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all dimensions of stigma across different levels. Obtain-
ing the views of wider stakeholders would provide fur-
ther insight into the barriers and facilitators to resource
allocations between mental and general health sectors.
Multi-morbidity including poor mental, physical health
and substance misuse and poor access to services can
lead to homelessness and social disparities [39–42].
There is a need to develop innovative services delivery
models, such as outreach programmes to support pa-
tients with severe mental health [43–45] and evaluate
their impact on health and quality-of-life outcomes.
Conclusions
This study demonstrates that barriers to monitoring,
counselling and management of cardiovascular and
metabolic health of patients taking antipsychotic medi-
cines are multidimensional. Knowledge-based interven-
tions alone will be insufficient in improving the practice.
There is a need to address the fragmentation of care,
lack of resources to address co-morbidity in clinical con-
sultations and stigma in the health-care setting. There is
a scope to develop, implement and evaluate peer and
family support-based interventions in improving the
practice.
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